101 related articles for article (PubMed ID: 32036218)
1. Targeting SGK1 enhances the efficacy of radiotherapy in locally advanced rectal cancer.
Zhou C; Xiao W; Jiang T; Guo Z; Li M; Chang H; Wu Y; Chen M; Shi M; Xu W; Gao Y
Biomed Pharmacother; 2020 May; 125():109954. PubMed ID: 32036218
[TBL] [Abstract][Full Text] [Related]
2. Role of SGK1 for fatty acid uptake, cell survival and radioresistance of NCI-H460 lung cancer cells exposed to acute or chronic cycling severe hypoxia.
Matschke J; Wiebeck E; Hurst S; Rudner J; Jendrossek V
Radiat Oncol; 2016 Jun; 11():75. PubMed ID: 27251632
[TBL] [Abstract][Full Text] [Related]
3. SGK1, the New Player in the Game of Resistance: Chemo-Radio Molecular Target and Strategy for Inhibition.
Talarico C; Dattilo V; D'Antona L; Menniti M; Bianco C; Ortuso F; Alcaro S; Schenone S; Perrotti N; Amato R
Cell Physiol Biochem; 2016; 39(5):1863-1876. PubMed ID: 27771704
[TBL] [Abstract][Full Text] [Related]
4. XRCC2 as a predictive biomarker for radioresistance in locally advanced rectal cancer patients undergoing preoperative radiotherapy.
Qin CJ; Song XM; Chen ZH; Ren XQ; Xu KW; Jing H; He YL
Oncotarget; 2015 Oct; 6(31):32193-204. PubMed ID: 26320178
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of SGK1 confers vulnerability to redox dysregulation in cervical cancer.
Wang M; Xue Y; Shen L; Qin P; Sang X; Tao Z; Yi J; Wang J; Liu P; Cheng H
Redox Biol; 2019 Jun; 24():101225. PubMed ID: 31136958
[TBL] [Abstract][Full Text] [Related]
6. Opposite effects of serum- and glucocorticoid-regulated kinase-1 and glucocorticoids on POMC transcription and ACTH release.
Reiter MH; Vila G; Knosp E; Baumgartner-Parzer SM; Wagner L; Stalla GK; Luger A
Am J Physiol Endocrinol Metab; 2011 Aug; 301(2):E336-41. PubMed ID: 21586695
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of serum- and glucocorticoid-inducible kinase 1 enhances TLR-mediated inflammation and promotes endotoxin-driven organ failure.
Zhou H; Gao S; Duan X; Liang S; Scott DA; Lamont RJ; Wang H
FASEB J; 2015 Sep; 29(9):3737-49. PubMed ID: 25993992
[TBL] [Abstract][Full Text] [Related]
8. Pivotal role of serum- and glucocorticoid-inducible kinase 1 in vascular inflammation and atherogenesis.
Borst O; Schaub M; Walker B; Schmid E; Münzer P; Voelkl J; Alesutan I; Rodríguez JM; Vogel S; Schoenberger T; Metzger K; Rath D; Umbach A; Kuhl D; Müller II; Seizer P; Geisler T; Gawaz M; Lang F
Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):547-57. PubMed ID: 25614279
[TBL] [Abstract][Full Text] [Related]
9. Serum and glucocorticoid kinase 1 promoted the growth and migration of non-small cell lung cancer cells.
Xiaobo Y; Qiang L; Xiong Q; Zheng R; Jianhua Z; Zhifeng L; Yijiang S; Zheng J
Gene; 2016 Jan; 576(1 Pt 2):339-46. PubMed ID: 26548813
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide RNAi Screening Identifies RFC4 as a Factor That Mediates Radioresistance in Colorectal Cancer by Facilitating Nonhomologous End Joining Repair.
Wang XC; Yue X; Zhang RX; Liu TY; Pan ZZ; Yang MJ; Lu ZH; Wang ZY; Peng JH; Le LY; Wang GY; Peng QH; Meng Y; Huang W; Liu RY
Clin Cancer Res; 2019 Jul; 25(14):4567-4579. PubMed ID: 30979744
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of serum- and glucocorticoid-inducible kinase 1 (SGK1) splice variants based on alternative initiation of transcription.
Simon P; Schneck M; Hochstetter T; Koutsouki E; Mittelbronn M; Merseburger A; Weigert C; Niess A; Lang F
Cell Physiol Biochem; 2007; 20(6):715-28. PubMed ID: 17982254
[TBL] [Abstract][Full Text] [Related]
12. Preclinical model in HCC: the SGK1 kinase inhibitor SI113 blocks tumor progression in vitro and in vivo and synergizes with radiotherapy.
Talarico C; D'Antona L; Scumaci D; Barone A; Gigliotti F; Fiumara CV; Dattilo V; Gallo E; Visca P; Ortuso F; Abbruzzese C; Botta L; Schenone S; Cuda G; Alcaro S; Bianco C; Lavia P; Paggi MG; Perrotti N; Amato R
Oncotarget; 2015 Nov; 6(35):37511-25. PubMed ID: 26462020
[TBL] [Abstract][Full Text] [Related]
13. SGK1 inhibition-induced autophagy impairs prostate cancer metastasis by reversing EMT.
Liu W; Wang X; Wang Y; Dai Y; Xie Y; Ping Y; Yin B; Yu P; Liu Z; Duan X; Liao Z; Chen Y; Liu C; Li X; Tao Z
J Exp Clin Cancer Res; 2018 Apr; 37(1):73. PubMed ID: 29609629
[TBL] [Abstract][Full Text] [Related]
14. The serum and glucocorticoid-regulated kinase 1 in hypoxic renal injury.
Rusai K; Wagner B; Roos M; Schmaderer C; Strobl M; Boini KM; Grenz A; Kuhl D; Heemann U; Lang F; Lutz J
Cell Physiol Biochem; 2009; 24(5-6):577-84. PubMed ID: 19910698
[TBL] [Abstract][Full Text] [Related]
15. SGK1, autophagy and cancer: an overview.
Ghani MJ
Mol Biol Rep; 2022 Jan; 49(1):675-685. PubMed ID: 34669124
[TBL] [Abstract][Full Text] [Related]
16. Colorectal carcinoma cells--regulation of survival and growth by SGK1.
Lang F; Perrotti N; Stournaras C
Int J Biochem Cell Biol; 2010 Oct; 42(10):1571-5. PubMed ID: 20541034
[TBL] [Abstract][Full Text] [Related]
17. Serum and Glucocorticoid Inducible Kinase 1-Sensitive Survival, Proliferation and Migration of Rhabdomyosarcoma Cells.
Schmid E; Stagno MJ; Yan J; Schleicher S; Yu W; Honisch S; Lang F; Fuchs J; Seitz G
Cell Physiol Biochem; 2017; 43(3):1301-1308. PubMed ID: 28992614
[TBL] [Abstract][Full Text] [Related]
18. Cytoplasmic translocation of MTA1 coregulator promotes de-repression of SGK1 transcription in hypoxic cancer cells.
Marzook H; Deivendran S; George B; Reshmi G; Santhoshkumar TR; Kumar R; Pillai MR
Oncogene; 2017 Sep; 36(37):5263-5273. PubMed ID: 28504714
[TBL] [Abstract][Full Text] [Related]
19. Serum/glucocorticoid-regulated kinase 1 as a novel transcriptional target of bone morphogenetic protein-ALK1 receptor signaling in vascular endothelial cells.
Araki M; Hisamitsu T; Kinugasa-Katayama Y; Tanaka T; Harada Y; Nakao S; Hanada S; Ishii S; Fujita M; Kawamura T; Saito Y; Nishiyama K; Watanabe Y; Nakagawa O
Angiogenesis; 2018 May; 21(2):415-423. PubMed ID: 29478089
[TBL] [Abstract][Full Text] [Related]
20. GR, Sgk1, and NDRG1 in esophageal squamous cell carcinoma: their correlation with therapeutic outcome of neoadjuvant chemotherapy.
Ueki S; Fujishima F; Kumagai T; Ishida H; Okamoto H; Takaya K; Sato C; Taniyma Y; Kamei T; Sasano H
BMC Cancer; 2020 Feb; 20(1):161. PubMed ID: 32106831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
